- Home
- BSET vs CNTB Comparison
BSET vs CNTB Comparison
Compare BSET & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSET | CNTB |
|---|---|---|
| Founded | 1902 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.4M | 157.1M |
| IPO Year | 1987 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BSET | CNTB |
|---|---|---|
| Price | $17.22 | $2.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 23.3K | ★ 440.3K |
| Earning Date | 01-28-2026 | 03-31-2026 |
| Dividend Yield | ★ 4.65% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $330,953,000.00 | $762,000.00 |
| Revenue This Year | $3.11 | N/A |
| Revenue Next Year | $3.00 | $38,289.22 |
| P/E Ratio | $19.21 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.62 | $0.51 |
| 52 Week High | $19.75 | $3.28 |
Technical Indicators
Market Signals| Indicator | BSET | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 68.97 | 45.72 |
| Support Level | $15.01 | $2.03 |
| Resistance Level | $17.51 | $2.38 |
| Average True Range (ATR) | 0.58 | 0.17 |
| MACD | 0.19 | -0.07 |
| Stochastic Oscillator | 90.80 | 26.79 |
Price Performance
Historical ComparisonAbout BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.